The combination of RPI, a genetically engineered herpes simplex virus type 1, and Opdivo shrank both injected and non-injected tumors by 30%.

A new treatment for advanced melanoma is showing promising results for people whose tumors have stopped responding to ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...

Sexually transmitted infections (STIs) are among the most common, yet least, discussed health concerns affecting adolescent ...

DelveInsight's, “Oncolytic Virus Cancer Therapy Pipeline Insight, 2025,” report provides comprehensive insights about 120+ ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

A new study finds that prior herpesvirus infections are linked to a faster age-related increase in blood biomarkers ...

Malignant gliomas, which include glioblastomas, are the most frequent primary brain cancer and are associated with extremely poor prognosis. They nearly always recur after treatment, rapidly leading ...

Genital Herpes Market Size, Epidemiology, In-Market Drugs Sales, Pipeline Therapies, and Regional Outlook 2025-2035 The report provides a detailed analysis of the current genital herpes marketed drugs ...

State lawmakers unsuccessfully attempted to extend the law this year to cover the intentional exposure of other sexually ...

Iovance Biotherapeutics, Inc. stock faces challenges with disappointing Q1 earnings and competition. Click for why potential ...

Suck blisters, or chafed lips, are very common in breastfeeding babies. However, this doesn't mean they're normal. Read on to ...